다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

IMNM

Immunome (IMNM)

Immunome Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:IMNM

1 2 3 4 5 6 7 8 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/20	21:00	Business Wire	Immunome Announces Completion of Purchase of Assets from Atreca	NASDAQ:IMNM	Immunome Inc
2024/05/18	06:11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMNM	Immunome Inc
2024/05/17	21:00	Business Wire	Immunome Announces Promotion of Max Rosett to Chief Financial Officer	NASDAQ:IMNM	Immunome Inc
2024/05/14	21:48	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:IMNM	Immunome Inc
2024/05/14	21:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IMNM	Immunome Inc
2024/05/14	21:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMNM	Immunome Inc
2024/05/14	21:00	Business Wire	Immunome Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:IMNM	Immunome Inc
2024/05/08	21:00	Business Wire	Immunome to Present at 2024 Bank of America Healthcare Conference	NASDAQ:IMNM	Immunome Inc
2024/05/02	21:00	Business Wire	Immunome Appoints Kinney Horn as Chief Business Officer	NASDAQ:IMNM	Immunome Inc
2024/04/25	21:26	Business Wire	Immunome Appoints Sandra M. Swain to Board of Directors	NASDAQ:IMNM	Immunome Inc
2024/04/05	21:00	Business Wire	Immunome to Present Preclinical Data for IM-3050, Its Lead Radioligand Therapy Candidate, at 2024 American Association for Cancer Research (AACR) Annual Meeting	NASDAQ:IMNM	Immunome Inc
2024/03/29	05:02	Business Wire	Immunome Reports Full Year 2023 Financial Results and Provides Update on Recently Acquired Assets	NASDAQ:IMNM	Immunome Inc
2024/03/26	21:00	Business Wire	Immunome Completes Acquisition of AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala	NASDAQ:IMNM	Immunome Inc
2024/03/07	22:00	Business Wire	Immunome to Participate in the Leerink Partners Global Biopharma Conference	NASDAQ:IMNM	Immunome Inc
2024/03/01	22:00	Business Wire	Immunome to Participate in the TD Cowen 44th Annual Healthcare Conference	NASDAQ:IMNM	Immunome Inc
2024/02/22	11:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMNM	Immunome Inc
2024/02/22	11:07	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:IMNM	Immunome Inc
2024/02/20	22:15	Business Wire	Immunome Recognizes Ayala Pharmaceuticals’ Announced Completion of Enrollment in Phase 3 RINGSIDE Study Evaluating AL102 in Desmoid Tumors	NASDAQ:IMNM	Immunome Inc
2024/02/17	06:05	Business Wire	Immunome Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares	NASDAQ:IMNM	Immunome Inc
2024/02/15	06:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMNM	Immunome Inc
2024/02/15	06:09	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:IMNM	Immunome Inc
2024/02/14	12:38	Business Wire	Immunome Announces Pricing of Public Offering of Common Stock	NASDAQ:IMNM	Immunome Inc
2024/02/14	06:36	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:IMNM	Immunome Inc
2024/02/14	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMNM	Immunome Inc
2024/02/14	06:05	Business Wire	Immunome Announces Proposed Public Offering of Common Stock	NASDAQ:IMNM	Immunome Inc
2024/02/13	04:10	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:IMNM	Immunome Inc
2024/02/06	22:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMNM	Immunome Inc
2024/02/05	22:00	Business Wire	Immunome to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference	NASDAQ:IMNM	Immunome Inc
2024/02/03	06:04	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:IMNM	Immunome Inc
2024/02/01	10:53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMNM	Immunome Inc

검색 관련기사 보기:NASDAQ:IMNM

1 2 3 4 5 6 7 8 다음 >>

Verizon Communications

Health Care Select Sector

Invesco QQQ Trust Series 1

Bank of America

Deutsche Telekom (QX)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관